Sclerema neonatorum (SN) is a rare clinical condition usually seen during the 1 st week of life. It presents as hardening of the skin and has a high mortality rate. It is usually associated with congenital anomalies, hypothermia, respiratory illnesses, and sepsis. Defective lipolytic enzymes, a high melting point, and resultant low solidification point of saturated fatty acids of subcutaneous fat, edema of connective tissue septae, and signs of underlying systemic diseases are the various theories proposed for the development of SN. The skin biopsy shows the thickening of trabeculae, sparse inflammatory infiltrates of lymphocytes, histiocytes and multinucleate giant cells, and X-ray diffraction of a biopsy sample of SN shows crystals in affected sites. The systemic corticosteroids have been used by various authors with variable response. Use of exchange transfusion has recently shown good results in improving the outcome of SN.
Introduction
Sclerema neonatorum (SN) is clinically characterized by induration of the skin and subcutaneous tissue, which often starts in the buttocks and thighs and then spreads to other parts of the body. Gray defined it as a condition invariably occurring in the 1 st weeks of life, occasionally present at birth, and characterized by the gradual development of sharply defined indurated areas in the subcutaneous tissues. [1] It commonly affects thighs, buttocks, scapular region, deltoid region, and the cheeks. The genitalia, palms, and soles are spared. [2] The skin of the child is cold and stiff. Hence, there is difficulty in sucking, respiration, and body movements. SN is slightly more common in the male with a sex ratio of 1.5:1. [3] SN is now a rare disease, precipitated by prematurity, asphyxia, and hypothermia. [4, 5] The summary of published studies on SN is shown in Table 1 . For this review, the information was collected by PubMed, Google Scholar, and Scopus search including original articles, review articles, and case reports. The keywords sclerma neonatorum ("SN") were used for the search.
History
In 1718, Uzembezius used the term "Acute sclerema" for SN. [9, 15] Underwood presented a detailed description in 1784 as "Skinbound." [9, 15, 16] Andry in 1785 assumed that the "Endurcissement du tissue cellulaire" and "Skinbound" were the same diseases. [16, 17] However, Chaussier in 1815 used the term "Sclereme" for "Endurcissement du tissue cellulaire." In 1877, "Endurcissement du tissue cellulaire" was replaced by a new term, "oedema neonatorum." Later, skinbound and "oedema neonatorum" were collectively given the term SN. [16, 17] Bernheimer-Karrer called the condition "Benign Sclerema" in 1922. [15] SN and subcutaneous fat necrosis of the newborn were described as the same disease by Gray in 1926.
Pathogenesis
SN mostly affects preterm neonates in the 1 st week of life. It is associated with many underlying conditions. They are gastroenteritis, pneumonia, congenital heart defects, hypothermia, septicemia, respiratory distress syndrome, septic shock, metabolic acidosis, severe malnutrition, transient hyperammonemia of the newborn, intestinal obstruction and therapeutic hypothermia. [5, [18] [19] [20] [21] In a study, Pelet found the low levels of C3 and factor B in sclerema with septicemia in newborn infants. [22] However, after transfusion, these levels became normal. Hence, they postulated defective activation of complement pathways for pathogenesis of SN. The pathogenesis of SN is explained by various theories. Earlier SN was thought to be a sign of grave underlying disorders requiring specific treatment for the same and was regarded as a special form of edema affecting the connective tissue septae causing thickening of the skin. [9, 11, 17, 23] Now, recently two more theories have been proposed.
High melting and a low solidification point of saturated fat theory
The fatty acids in the neonate are predominantly composed of saturated fatty acids, thus having a high melting point and a low solidification point. Hence, they have a tendency to harden at low body temperature. [24] Hughes and Hammond support this idea. They proposed that SN occurs due to circulatory collapse secondary to shock causing low peripheral body temperature leading to hardening of the skin. [14] Elliott argues against this theory. [17] 
Defective fat metabolism theory
The second theory ascribes SN to be due to defective fat metabolism. A defect in adipose lipolytic enzymes or in one of the lipid transport mechanisms are believed to be the main underlying factors responsible for SN. Hence, there is hardening of the skin due to defective immobilization of fatty acids from the subcutaneous adipose tissue. [23] 
Investigations
The chemistry of the subcutaneous fat of the sclerematous infant was extensively studied by various authors. [24] [25] [26] They found that the oleic acid content was decreased. The crystals seen in the affected fat were shown to be the properties of triglycerides. The X-ray diffraction of the biopsy sample of SN shows that the crystals in affected sites are larger than the normal subcutaneous fat. [27] The epidermis and dermis are normal with sparse inflammatory infiltrate within the fat tissue. The fat spaces are diminished and trabeculae are broadened without fat necrosis. [23, 28] Dasgupta et al. showed subcutaneous fibrosis with lobulation. [6] Many authors reported that if the sclerematous lesion breaks down to form a sterile abscess, such crystals can be aspirated. [25, 29] There is reduced iodine value and a raised melting point of the fat. Based on this finding, Channon and Harrison found increased ratio of saturated to the unsaturated fatty acids. [24] Sweeney et al. found that triglyceride constituted 98%-99% of subcutaneous fat in 6-7-week old normal infants. [30] In a study, Horsfield and Yardley found that there is a significant decrease in oleic acid contents in subcutaneous fat as well as in dermis and epidermis in SN. A complete sepsis workup should be initiated in all infants with sclerema neonatorum. [27] 
Clinical Features
Physical findings of SN appear suddenly, first on the thighs and buttocks and spread rapidly, often affecting all parts of the body except the palms, soles, and genitalia. The onset of SN is usually at birth or during the 1 st week of life. However, Spohn et al. recently reported a delayed onset [6] 1993 10
Histopathological study of 10 cases of sclerema neonatorum showed subcutaneous fibrosis with lobulation in all the cases. 8 (80%) cases showed nonspecific chronic inflammation of dermis and thinning of epidermis with atrophy of rete pegs and hypercollgenisation of dermis was evident in 70 percent cases Pasyk [7] 1980 4
The connective tissue bands of the cutis and subcutis were thickened and alternated with loosely distributed bands in broad, distended areas of basal substance. In the interlobular septa of the subcutaneous and perirenal fat splitting of fibers into microfibrils was visible Bwibo and Anderson [8] 1970 16 Most of the patients were preterm and onset within 14 days of birth.
The associated comorbidities were respiratory distress syndrome and salmonella enteritis Villacorte and Frank [9] 1967 9
In most of the patients, onset was within first 7 days of birth. All infants had mild-to-moderate respiratory distress at or shortly after birth and 5 also developed jaundice. Six had complications Khetarpal and Subrahmanyam [10] 1964 17 The associated comorbidities were septicemia and jaundice
Most of the patients were preterm and 15 had no complications Warwick et al. [11] 1963 18 Out of 18 patients, nine had complications. Sepsis, respiratory problems, and multiple congenital anomalies were associated comorbidities Levin et al. [12] 1961 25 Two cases were improved with hydrocortisone out of 11 cases while three out of 14 without hydrocortisone got remission Bower et al. [13] 1960 14 In a study by Bower et al., nine infants survived with antibiotics without steroids Hughes and Hammond [14] 1948 19 Mothers of 4 babies had complications such as preeclampsia, eclampsia, placenta previa, and cord compression Six babies had cyanosis and eleven had temperature instability of SN in the Neonatal Intensive Care Unit. [31] The involved skin is pale, waxy, and firm to palpation [ Figure 1 ]. The skin cannot be pitted or pinched up [ Figure 1 ] because it is bound to underlying subcutaneous tissue, muscle, and bone. The affected infant often displays flexion contractures at the elbow, knee, and hip joints; temperature instability; restricted respiration; difficulty in feeding; and decreased spontaneous movement. Newborns may also present with mask-like facies or "pseudotrismus," an inability to completely open the mouth, secondary to the thickening of the skin over the face, arms, and hands. [4] Pulse, temperature, and respiratory rate are decreased, and there is difficulty in respiration and movement. No seasonal variation or maternal parity was associated with SN. [10] Underwood listed the following pathognomonic symptoms of SN [ Table 2 ]. [32] Subcutaneous fat necrosis of the newborn (SCFN) and scleredema are the two other related diseases which have to be differentiated from SN. SCFN affects postmature neonates during the first 4 weeks of life as compared to SN, which is usually seen in premature neonates. Clinically, it presents as circumscribed areas of hardness attached to the skin, move freely over muscles and bone, and generally do not spread. It usually appears in healthy neonates. The histologic findings of sclerema neonatorum are subtle, The most consistent findings are edema, a thickening of the subcutaneous fibrous septa, and a radial array of fine, needlelike clefts in the fat cells, representing former sites of fat crystals. The lack of a granulomatous inflammation and the absence of fat necrosis help distinguish sclerema neonatorum from subcutaneous fat necrosis of the newborn.
Treatment
Careful handling of the newborn, proper temperature control, rational use of antibiotics, and fluid and electrolyte correction has improved the prognosis of neonatal septicemia. But still, septicemia is an important cause of neonatal mortality. Recently, steroid therapy and exchange transfusion (ET) have significantly improved the outcome of SN.
Many authors have emphasized the importance of treating the underlying disease. [9, 11, 14] The outcome of SN might be influenced by use of antibiotics. In a study by Bower et al., nine out of 14 full-term infants with sclerema who received antibiotics without the addition of steroids survived. [13] There are other reports, in which improvement of SN with antibiotics has been reported. [12] Steroids have been used in SN, but with variable result.
Cortisone was first used in SN by Kendig and Toone with good recovery. Kendall and Ledis gave A.C.T.H. with same dramatic outcome. [32] Beneficial effect of steroids in SN was proposed by Marks as adjunctive therapy. [33] Levin et al. reported improved outcome in a comparative study in 25 patients with or without hydrocortisone. Shrestha et al. also managed SN with parenteral steroids. [34] Out of 11 children treated with hydrocortisone, remission was seen only in two cases, as compared to controls in which three survived out of 14 patients. [12] Therefore, there is yet no certain evidence to use corticosteroids in SN. Hence, further studies are required. Hughes and Hammond did a review of the literature and collected 16 cases of SN. They also reported three cases. Out of 19 patients, only five survived. [14] Recently, the use of ET has shown promising results in improving outcome of SN. Xanthou et al. performed ET in two critically ill patients with sclerema. They found good improvement and the sclerema disappeared within 3-4 days. [35] In another study, Sadana et al. found greater survival of babies with premature birth (28-to 32-week gestation) than those born >32 weeks of gestation after ET. [36] The mechanism by which ET works in SN might be due to immunological components, including enhanced humoral and cellular immunity that are provided through ET to the immunologically immature neonates, or by improving oxygen transportation by improving the circulation and shifting the oxygen dissociation curve to the right, correcting hypovolemia, improving hemostatic mechanisms, and removing bacteria or bacterial toxins. [35, [37] [38] [39] Hence, there is increased survival in patients 1 . The skin is always of a yellowish-white color, giving the idea of soft wax 2. The feel of the skin and flesh is hard and resisting, but not edematous 3. The cellular membrane is fixed in such a manner that the skin will not slide over the subjacent muscles; not even on the back of the hands, where it is usually very loose and pliable 4. The rigidity often extends over the whole body; however, the skin is peculiarly rigid in the parts about the face, and on the extremities 5. The child is always cold 6. The infant makes a peculiar moaning noise, which is often very feeble; and never cries like other children 7. Whatever number of days such children may survive, they always have the appearance of being dying with SN and sepsis when repeat ET is done early during the disease. Park et al. recently found a favorable prognosis of SN in a full-term infant. [40] Buster et al. recently reported a short-term clinical improvement with use of intravenous immunoglobulin in a patient of SN. [41] It probably helps by increasing both humoral and cellular immunity in the patient.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
